The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells

Journal of Hepatology

Volumn 61, Issue 5, 2014, Pages 1097-1105

  Riccio, Massimo ^a   Carnevale, Gianluca ^a   Cardinale, Vincenzo ^b   Gibellini, Lara ^a   De Biasi, Sara ^a   Pisciotta, Alessandra ^a   Carpino, Guido ^c   Gentile, Raffaele ^b   Berloco, Pasquale B ^b   Brunelli, Roberto ^b   Bastianelli, Carlo ^b   Napoletano, Chiara ^b   Cantafora, Alfredo ^b   Cossarizza, Andrea ^a   Gaudio, Eugenio ^b   Alvaro, Domenico ^b,d   De Pol, Anto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME FORO ITALICO   (Italy)

^d Fondazione Eleonora Lorillard Spencer Cenci   (Italy)

Author keywords

Endodermal stem cells; FasL; Human biliary tree stem progenitor cells (hBTSCs); Immune modulation; T cell apoptosis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN BILIARY TREE STEM PROGENITOR CELL; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MULTIPOTENT STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT STEM CELL; COCULTURE; CYTOLOGY; FETAL STEM CELL; HEPATOBILIARY SYSTEM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

ADULT STEM CELLS; ANTIGENS, CD95; APOPTOSIS; BILIARY TRACT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; FAS LIGAND PROTEIN; FETAL STEM CELLS; HUMANS; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MULTIPOTENT STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84932154584     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.06.016     Document Type: Article

References (26)

1. Cardinale V, Wang Y, Carpino G, Mendel G, Alpini G, Gaudio E, et al. The biliary tree -A reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 2012;9: 231-240.
2. Carpino G, Cardinale V, Onori P, Franchitto A, Berloco PB, Rossi M, et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intrahepatic bile ducts: An anatomical in situ study yielding evidence of maturational lineages. J Anat 2012;220: 186-199.
3. Cardinale V, Wang Y, Carpino G, Cui CB, Gatto M, Rossi M, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 2011;54: 2159-2172.
4. Semeraro R, Carpino G, Cardinale V, Onori P, Gentile R, Cantafora A, et al. Multipotent stem/progenitor cells in the human fetal biliary tree. J Hepatol 2012;57: 987-994.
5. Carpino G, Cardinale V, Gentile R, Onori P, Semeraro R, Franchitto A, et al. Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder. J Hepatol 2014. http://dx.doi.org/10.1016/j.jhep.2014.01.026.
6. Terasaki S, Nakanuma Y, Unoura M, Kaneko S, Kobayashi K. Involvement of peribiliary glands in primary sclerosing cholangitis: A histopathologic study. Intern Med 1997;36: 766-770.
7. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99: 3838-3843.
8. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107: 367-372.
9. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005;80: 836-842.
10. Giuliani M, Fleury M, Vernochet A, Ketroussi F, Clay D, Azzarone B, et al. Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS One 2011;6: E19988.
11. Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymalstem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 2012;10: 544-555.
12. Zhao Y, Wang L, Jin Y, Shi S. Fas ligand regulates the immunomodulatory properties of dental pulp stem cells. J Dent Res 2012;91: 948-954.
13. Riccio M, Maraldi T, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, et al. Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Tissue Eng Part A 2012;18: 1006-1013.
14. Carnevale G, Riccio M, Pisciotta A, Beretti F, Maraldi T, Zavatti M, et al. In vitro differentiation into insulin-producing b-cells of stem cells isolated from human amniotic fluid and dental pulp. Dig Liver Dis 2013;45: 669-676.
15. Gibellini L, De Biasi S, Pinti M, Nasi M, Riccio M, Carnevale G, et al. The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes. AIDS 2012;26: 2017-2026.
16. Pisciotta A, Riccio M, Carnevale G, Beretti F, Gibellini L, Maraldi T, et al. Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo. PLoS One 2012;7: E50542.
17. Pearl-Yafe M, Yolcu ES, Stein J, Kaplan O, Shirwan H, Yaniv I, et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol 2007;35: 1601-1612.
18. O' Reilly LA, Tai L, Lee L, Kruse EA, Grabow S, Fairlie WD, et al. Membranebound Fas ligand only is essential for Fas-induced apoptosis. Nature 2009;461: 659-663.
19. Mazar J, Thomas M, Bezrukov L, Chanturia A, Pekkurnaz G, Yin S, et al. Cytotoxicity mediated by the Fas ligand (FasL)-Activated apoptotic pathway in stem cells. J Biol Chem 2009;284: 22022-22028.
20. Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: Current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010;7: 288-298.
21. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 2010;19: 409-418.
22. Gridelli B, Vizzini G, Pietrosi G, Luca A, Spada M, Gruttadauria S, et al. Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transpl 2012;18: 226-237.
23. Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol 2013;59: 571-582.
24. Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G. Characterization of hepatic progenitors from human fetal liver during second trimester. World J Gastroenterol 2008;14: 5730-5737.
25. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204: 1973-1987.
26. Lee JH, Park HJ, Kim YA, Lee DH, Noh JK, Kwon CH, et al. Differentiation and major histocompatibility complex antigen expression in human liverderived stem cells. Transplant Proc 2012;44: 13-15.